Case report
A 40-year-old man was diagnosed with AML in January We report an unusual case of a patient who was cured of one autoimmune disease (palmoplantar pustular pso-1992. Bone marrow cytology revealed M6 by the FAB classification with trilineage myelodysplasia. The patient riasis (PPP)) but developed another autoimmune disease (autoimmune thyroiditis) after allogeneic BMT. A 40-went into complete remission following induction chemotherapy with daunorubicin, 6-mercaptopurine, and behenoyl year-old man suffering from AML with PPP underwent allogeneic BMT from his HLA-identical sister for the cytosine arabinoside. After receiving three courses of consolidation chemotherapy, he developed skin lesions on the treatment of AML. The patient experienced complete clearance of the cutaneous PPP despite the cessation of palms and soles ( Figure 1 ). The skin lesions were diagnosed as PPP by histological examination in February 1993. immunosuppressive therapy for over 2 years. However, he developed hyperthyroidism with anti-thyroglobulin They were treated with combinations of topical corticosteroids and etretinate, but showed only partial response. antibodies 5 months after BMT, although he had showed normal thyroid functions without anti-thyrogloIn November 1993, after myeloablation with BU (16 mg/kg) and CY (120 mg/kg), the patient received an bulin antibodies before BMT. The donor had no history of thyroid diseases and showed normal thyroid funcallogeneic BMT from his HLA-identical younger sister, who did not suffer from PPP. The mixed lymphocyte reactions but was positive for anti-thyroglobulin antibodies. Thus, even when the donor is in a subclinical state, autotion was negative. Although the patient's elder sister had died of hyperthyroidism, his younger sister had no history immune thyroiditis may be transferred from donors to recipients by BMT.
of thyroid diseases and showed normal thyroid functions, but was positive for anti-thyroglobulin antibodies. Keywords: autoimmune thyroiditis; palmoplantar pustular psoriasis; bone marrow transplantation; autoimmunity CYA and MTX were used for GVHD prophylaxis. The hematological follow-up showed stable engraftment with complete hematopoietic recovery and sustained complete chimerism. There were no signs of acute GVHD. After his It is well known that the hematopoietic and immune system of recipients is eventually replaced by donor-derived cells after allogeneic BMT. Experimental work in animal models has demonstrated that BMT can be used to treat systemic and organ-specific autoimmune diseases.
1 In humans, the resolution of immune-mediated diseases after BMT has recently been reported. [2] [3] [4] On the other hand, autoimmune diseases have also been transferred from donors to recipients in both mice 5 and humans [6] [7] [8] by BMT. We report the unusual case of a patient who was cured of palmoplantar pustular psoriasis (PPP) but developed autoimmune thyroiditis after allogeneic BMT. This is the first case report in which a pre-existing immune-mediated disease was cured while an autoimmune disease was transferred by BMT. Five months after BMT, the patient showed weight loss the adoptive transfer of autoimmune thyroiditis has been previously reported, 6 ,7 the transfer of subclinical thyroiditis (5 kg); in addition, he complained of general malaise and fever. There was no enlargement of the thyroid gland. The from a donor has not. The anti-microsomal antibodies which developed 18 months after BMT may have been findings of thyroid tests and autoantibody levels are summarized in Table 1 ; these showed normal thyroid functions newly acquired autoantibodies because of the long-lasting thyroiditis. Since thyroid failure may occur years after the and no anti-thyroid autoantibodies prior to BMT, although hyperthyroidism with anti-thyroglobulin antibodies development of autoantibodies, long-term monitoring of thyroid functions is required. developed 5 months after BMT, followed by euthyroidism with the presence of both anti-thyroglobulin and antiAlthough this report suggests the transfer of autoimmune thyroiditis by bone marrow cells, other mechanisms are microsomal antibodies 18 months after BMT. The patient was negative for other autoantibodies such as anti-nuclear possible. As there was a family history of thyroid disease (hyperthyroidism), the recipient may have had a genetic antibodies, anti-mitochondrial antibodies and anti-thyroidstimulating hormone (TSH) receptor antibodies. At that predisposition to thyroid diseases. On the other hand, the de novo development of autoimmune disorders has been time, he also developed lichen planus on his buccal mucosa. The mucosal biopsy showed findings consistent with those reported in chronic GVHD. 9 Although chronic GVHD may also have accelerated the autoimmune thyroiditis, the develof chronic GVHD. Although CYA (3 mg/kg) was given daily, prednisolone (40 mg/day) was also administered.
opment of anti-thyroid autoantibodies is rarer than other autoantibodies in chronic GVHD. 10 The general immune After immunosuppression with CYA and prednisolone, clinical symptoms improved, and thyroid functions returned dysregulation after BMT may have contributed to an acceleration of autoimmune thyroiditis. to normal in a few weeks. One year after BMT, CYA and prednisolone were discontinued. The patient remained in PPP is a chronic recurrent pustular dermatosis localized to the palms and soles, and is characterized by the appearcomplete remission from his leukemia and had normal thyroid functions but continued to show a high titer of antiance of sterile, intraepidermal pustules. It is highly resistant to treatment. 11 The powerful immunosuppressive prepthyroid autoantibodies such as anti-thyroglobulin and antimicrosomal antibodies. The karyotypic examination of the aration for BMT may have modified the clinical course of PPP, and the patient showed a complete clearance of his bone marrow confirmed complete chimerism with donor cells. Two years after BMT, the patient showed complete PPP following allogeneic BMT. In the pathogenesis of psoriasis vulgaris, immunological mechanisms play an clearance of his cutaneous PPP despite the cessation of immunosuppressive therapy.
important role, and the clearance of the disease following allogeneic BMT has been reported. 2, 3 Although it has been shown that some clinical, histological and genetic differences may exist between PPP and psoriasis vulgaris, 12 the Discussion immunofluorescent reactivity of immune components in the skin has been reported to be identical. 13 Thus, this case may We have reported a case of the development of autoimmune thyroiditis in a recipient after allogeneic BMT; the disease demonstrate that PPP is an immune-mediated disease, as is psoriasis vulgaris, and the eradication of the recipient's was presumed to have been caused by adoptive transfer of immunocompetent cells from the donor. Chromosome bone marrow-derived immune system and its replacement with the donor's immune system can bring about a comanalyses revealed that the hematolymphoid cells of the recipient were of donor origin. Thus, it is likely that the plete remission of PPP. Indeed, in mouse experiments, it has been shown that production of anti-thyroid antibodies and the destruction of the thyroid tissue were due to lymphoid cells from the autoimmune diseases can be cured after BMT, and that the transplantation of a stem cell-enriched population from donor. We speculate that the subclinical autoimmune disautoimmune-prone mice leads to the induction of autoimmune diseases in normal mice. 5 Based on these findings, 
